[Short-term and long-term efficacy of topiramate in refractory generalized epilepsy of children].

Abstract

Topiramate (TPM) was administered to 25 children with intractable generalized epilepsy. A > or =50% decrease in seizure frequency was observed in 56% and 45% of children at two months and one year after initiation of TPM therapy, respectively. However, efficacy of TPM for Lennox-Gastaut syndrome was low. TPM therapy was discontinued in five of 25 children at 3-5.5 months due to lack of efficacy or aggravation of seizures. No serious adverse effects were observed during TPM therapy. The present study revealed that TPM has clinical efficacy in the treatment of children with intractable generalized epilepsy.

• Authors: Toshihide Watanabe, Reiki Oyanagi, Kimio Minagawa
• Journal: No to hattatsu = Brain and development (No To Hattatsu) Vol. 43 Issue 3 Pg. 223-7 (May 2011) ISSN: 0029-0831 [Print] Japan
• PMID: 21638908 (Publication Type: Journal Article)

Chemical References

• Anticonvulsants
• Topiramate
• Fructose

Topics

• Adolescent
• Adult
• Anticonvulsants (therapeutic use)
• Child
• Child, Preschool
• Epilepsy, Generalized (drug therapy)
• Female
• Fructose (analogs & derivatives, therapeutic use)
• Humans
• Infant
• Male
• Topiramate
• Treatment Outcome